본문 바로가기
KERD
논문KCI 등재

태아발육지연 처치의 최신 지견

Recent advances in management of fetal growth restriction

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류산부인과학

초록

태아발육지연은 자궁 내에서 태아의 성장 속도가 감소하여 유전적으로 주어진 잠재적인 성장을 이루지 못하는 경우로, 전체 임신의 약 3% 정도에서 나타나는 드물지 않은 질환이다. 불량한 자궁태반 혈류나 태반의 경색 등에 의해 발생하는 자궁태반 기능부전이 태아발육지연의 가장 흔한 원인이며, 이로 인해 태반을 통한 영양 공급이 감소되면 태반과 태아 모두에서 이에 적응하려는 병적인 변화가 일어나게 되는데 이러한 변화들을 감지하여 정상적인 부당 경량아와 태아발육지연을 구별하고, 그 원인을 찾아 교정할 수 있는 경우 교정하며, 교정이 불가능할 경우 진행 정도를 정확히 파악하여 최적의 시점에 분만하게 하는 것이 산과 의사의 몫이라 하겠다. 본 종설에서는 태아발육지연의 선별과 진단 및 산전 감시에 대해 알아보고, 그 원인과 여러 가지 치료적 접근법을 열거한 후, 이를 종합하여 태아발육지연의 처치에 대해 정리해 보고자 한다.

참고문헌 (55)

  1. Illanes S, "Management of fetal growth restriction", Semin Fetal Neonatol Med, 9, pp.395~401 (2004)
  2. Odegard RA, "Preeclampsia and fetal growth", Obstet Gynecol, 96, pp.950~955 (2000)
  3. "High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss", Acta Obstet Gynecol Scand, 79, pp.963~967 (2000)
  4. Wisser J, "Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos", Ultrasound Obstet Gynecol, 4, pp.457~462 (1994)
  5. Jones TB, "Biparietal diameter and femur length discrepancies: are maternal characteristics important?", Ultrasound Obstet Gynecol, 1, pp.405~409 (1991)
  6. Jacobsen G, "Prediction of fetal growth deviations by use of symphysis-fundus height measurements", Int J Technol Assess Health Care, 8, pp.152~159 (1992)
  7. Lu MC, "Preventing low birth weight: is prenatal care the answer?", J Matern Fetal Neonatal Med, 13, pp.362~380 (2003)
  8. Bobrow CS, "Fetal growth velocity: a cautionary tale", Lancet, 353, pp.1460~ (1999)
  9. Maulik D, "Fetal growth restriction: the etiology", Clin Obstet Gynecol, 49, pp.228~235 (2006)
  10. Sibai BM, "Chronic hypertension in pregnancy", Obstet Gynecol, 100, pp.369~377 (2002)
  11. Polzin WJ, "The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction", Obstet Gynecol, 78, pp.1108~1111 (1991)
  12. Bracken MB, "Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies", Obstet Gynecol, 102, pp.739~752 (2003)
  13. Schatz M, "Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis", Am J Respir Crit Care Med, 151, pp.1170~1174 (1995)
  14. Kramer MS, "Intrauterine growth and gestational duration determinants", Pediatrics, 80, pp.502~511 (1987)
  15. Cliver SP, "The effect of cigarette smoking on neonatal anthropometric measurements", Obstet Gynecol, 85, pp.625~630 (1995)
  16. Bahado-Singh RO, "First-trimester growth restriction and fetal aneuploidy: the effect of type of aneuploidy and gestational age", Am J Obstet Gynecol, 176, pp.976~980 (1997)
  17. Khoury MJ, "Congenital malformations and intrauterine growth retardation: a population study", Pediatrics, 82, pp.83~90 (1988)
  18. Offenbacher S, "Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction", Ann Periodontol, 6, pp.164~174 (2001)
  19. Tamura RK, "Diminished growth in fetuses born preterm after spontaneous labor or rupture of membranes", Am J Obstet Gynecol, 148, pp.1105~1110 (1984)
  20. Bukowski R, "Impairment of growth in fetuses destined to deliver preterm", Am J Obstet Gynecol, 185, pp.463~467 (2001)
  21. Gardosi JO, "Prematurity and fetal growth restriction", Early Hum Dev, 81, pp.43~49 (2005)
  22. Guenwald P, "Growth of the human fetus: II. Abnormal growth in twins and infants of mothers with diabetes, hypertension, or isoimmunization", Am J Obstet Gynecol, 94, pp.1120~1132 (1966)
  23. Crane JP, "Ultrasonic growth patterns in normal and discordant twins", Obstet Gynecol, 55, pp.678~683 (1980)
  24. Soothill PW, "Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses", Br Med J (Clin Res Ed), 294, pp.1051~1053 (1987)
  25. Levene MI, "Fetal and neonatal neurology and neurosurgery", pp.459~468 (2001), Churchill Livingstone
  26. Baschat AA, "Integrated fetal testing in growth restriction: combining multivessel Doppler and biophysical parameters", Ultrasound Obstet Gynecol, 21, pp.1~8 (2003)
  27. Vandenbosche RC, "Intrauterine growth retardation", Am Fam Physician, 58, pp.1384~1390 (1998)
  28. Banks EH, "Perinatal risks associated with borderline amniotic fluid index", Am J Obstet Gynecol, 180(6), pp.1461~1463 (1999)
  29. Manning FA, "Fetal assessment based on fetal biophysical profile scoring. IV. An analysis of perinatal morbidity and mortality", Am J Obstet Gynecol, 162, pp.703~709 (1990)
  30. Baschat AA, "Antenatal assessment of the growth restricted fetus", Curr Opin Obstet Gynecol, 13, pp.161~168 (2001)
  31. Albaiges G, "One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’- gestation", Obstet Gynecol, 96, pp.559~564 (2000)
  32. Audibert F, "Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine doppler velocimetry", Fetal Diagn Ther, 20, pp.48~53 (2005)
  33. Bricker L, "Routine Doppler ultrasound in pregnancy", Cochrane Database Syst Rev, pp.CD001450~ (2000)
  34. Karsdorp VH, "Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery", Lancet, 344, pp.1664~1668 (1994)
  35. Soothill PW, "Small for gestational age is not a diagnosis", Ultrasound Obstet Gynecol, 13, pp.225~228 (1999)
  36. Bricker L, (2003)
  37. Vyas S, "Fetal Doppler studies in the hypoxic fetus. In: Ultrasound in obstetrics and gynecology", pp.619~624 (1993), Little, Brown and Co
  38. Dubiel M, "Blood redistribution in the fetal brain during chronic hypoxia", Ultrasound Obstet Gynecol, 20, pp.117~121 (2002)
  39. Weiner C, "Fetal growth restriction: evaluation and management. High risk pregnancy", pp.291~308 (1999)
  40. Baschat AA, "Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction", Ultrasound Obstet Gynecol, 16, pp.407~413 (2000)
  41. Bobrow CS, "Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and smallforgestational- age fetuses classified by umbilical artery Doppler ultrasound", Am J Obstet Gynecol, 186, pp.283~287 (2002)
  42. Holmes RP, "A prospective study of maternal serum insulin like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses", Br J Obstet Gynaecol, 105, pp.1273~1278 (1998)
  43. Ishihara N, "Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia of intrauterine growth retardation", Am J Obstet Gynecol, 186, pp.158~166 (2002)
  44. Nicolaides KH, "Maternal oxygen therapy for intrauterine growth retardation", Lancet, 1, pp.942~945 (1987)
  45. Johanson R, "A prospective randomised comparison of the effect of continuous O2 therapy and bed rest on fetuses with absent end-diastolic flow on umbilical artery Doppler waveform analysis", Br J Obstet Gynaecol, 102, pp.662~665 (1995)
  46. Kramer MS, "Energy and protein intake in pregnancy (Systematic Review). Cochrane Pregnancy and Childbirth Group", Cochrane Database Syst Rev, 3 (2005)
  47. Leitich H, "A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation", Br J Obstet Gynaecol, 104, pp.450~459 (1997)
  48. Coomarasamy A, "Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review", Obstet Gynecol, 101, pp.1319~1332 (2003)
  49. Say L, "Betamimetics for suspected impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group", Cochrane Database Syst Rev, 3 (2005)
  50. Say L, "Calcium channel blockers for potential impaired fetal growth (Systematic Review). Cochrane Pregnancy and Childbirth Group", Cochrane Database Syst Rev, 3 (2005)
  51. Lees C, "The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of preeclampsia and its complications: a randomized double-blind placebo-controlled trial", Ultrasound Obstet Gynecol, 12, pp.334~338 (1998)
  52. Sieroszewski P, "Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (Larginine)", J Matern Fetal Neonat Med, 15, pp.363~366 (2004)
  53. Soothill PW, "Relation of fetal hypoxia in growth retardation to mean blood velocity in the fetal aorta", Lancet, 2, pp.1118~1120 (1986)
  54. GRIT Study Group, "randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation", BJOG, 110, pp.27~32 (2003)
  55. Hecher K, "Monitoring of fetuses with intrauterine growth restriction: a longitudinal study", Ultrasound Obstet Gynecol, 18, pp.564~570 (2001)

관련 논문AI추천

이 간행물의 다른 논문 (13건)